Skip to main content

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.75
+4.47 (2.18%)
AAPL  271.91
+5.73 (2.15%)
AMD  214.49
+17.89 (9.10%)
BAC  50.55
-0.52 (-1.02%)
GOOG  310.69
-1.00 (-0.32%)
META  639.16
+1.91 (0.30%)
MSFT  388.58
+4.11 (1.07%)
NVDA  192.72
+1.16 (0.61%)
ORCL  146.40
+5.09 (3.60%)
TSLA  408.94
+9.12 (2.28%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.